DOSSIER · 13F Holders · Q2 2026Healthcare · Biological Products, (No Diagnostic Substances)
NVAX
NOVAVAX INC
285 institutions still hold NOVAVAX INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 670002401·Biological Products, (No Diagnostic Substances)·285 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
285 institutions reported NVAX in Q2 2026. SHAH CAPITAL MANAGEMENT leads at 13.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 15
265 more holders available. Log in →